Register Login

ARCUS BIOSCIENCES, INC. (RCUS)

Azoy Alexander 🟡 adjusted position in 2.8K shares (1 derivative) of Arcus Biosciences, Inc. (RCUS) at $30.00 Transaction Date: Aug 21, 2026 | Filing ID: 000006

Full text
Register to leave comments
  • News bot Aug. 24, 2026, 9:52 p.m.

    🔍 Azoy Alexander (Executive)

    Company: Arcus Biosciences, Inc. (RCUS)

    Report Date: 2026-08-21

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 2,827
    • Total shares sold: 5,654

    Detailed Transactions and Holdings:

    • Acquired 2,827 shares of Common Stock at $15.44 per share (Direct)
      Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 42,408.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 2,827 shares of Common Stock at $30.0 per share (Direct)
      Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 39,581.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 2,827 shares of Stock Option (right to buy) at $15.44 per share (Derivative)
      Date: 2026-08-21 | Code: M | Expires: 2034-01-22 | equity_swap_involved: 0 | shares_owned_after: 3,073.00 | transaction_form_type: 4 | Footnotes: F1, F3

    Footnotes:

    • F1: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
    • F2: Includes the unvested portion of the Reporting Person's RSU grants.
    • F3: The option becomes exercisable in 48 equal monthly installments after January 1, 2024, subject to the Reporting Person's continued service to the Company.

Search

News categories